Skip to main content
Erschienen in: Pediatric Radiology 11/2016

23.07.2016 | Review

The changing face of complicated infantile hemangioma treatment

verfasst von: Deanna Menapace, Mario Mitkov, Richard Towbin, Marcia Hogeling

Erschienen in: Pediatric Radiology | Ausgabe 11/2016

Einloggen, um Zugang zu erhalten

Abstract

Infantile hemangiomas are the most common vascular tumors of infancy. A multidisciplinary approach including dermatologists, otolaryngologists, plastic surgeons, hematologists/oncologists and interventional/diagnostic radiologists is crucial for appropriate management of children with complicated infantile hemangiomas. Since its unforeseen discovery in 2008, propranolol has become the first-line treatment for infantile hemangiomas, eclipsing systemic corticosteroids and radiologic intervention. There are still, however, uncommon indications for more aggressive interventional management. We review the 2014-updated International Society for the Study of Vascular Anomalies (ISSVA) classification for vascular anomalies. Additionally, we suggest management algorithms for complicated lesions, including recommendations for radiologic and surgical intervention.
Literatur
1.
Zurück zum Zitat Munden A, Butschek R, Tom WL et al (2014) Prospective study of infantile haemangiomas: incidence, clinical characteristics and association with placental anomalies. Br J Dermatol 170:907–913PubMedPubMedCentralCrossRef Munden A, Butschek R, Tom WL et al (2014) Prospective study of infantile haemangiomas: incidence, clinical characteristics and association with placental anomalies. Br J Dermatol 170:907–913PubMedPubMedCentralCrossRef
2.
Zurück zum Zitat Mueller BU, Mulliken JB (1999) The infant with a vascular tumor. Semin Perinatol 23:332–340PubMedCrossRef Mueller BU, Mulliken JB (1999) The infant with a vascular tumor. Semin Perinatol 23:332–340PubMedCrossRef
3.
Zurück zum Zitat Frieden IJ, Haggstrom AN, Drolet BA et al (2005) Infantile hemangiomas: current knowledge, future directions. Proceedings of a research workshop on infantile hemangiomas, April 7–9, 2005, Bethesda, MD. Pediatr Dermatol 22:383–406PubMedCrossRef Frieden IJ, Haggstrom AN, Drolet BA et al (2005) Infantile hemangiomas: current knowledge, future directions. Proceedings of a research workshop on infantile hemangiomas, April 7–9, 2005, Bethesda, MD. Pediatr Dermatol 22:383–406PubMedCrossRef
4.
Zurück zum Zitat Amir J, Metzker A, Krikler R et al (1986) Strawberry hemangioma in preterm infants. Pediatr Dermatol 3:331–332PubMedCrossRef Amir J, Metzker A, Krikler R et al (1986) Strawberry hemangioma in preterm infants. Pediatr Dermatol 3:331–332PubMedCrossRef
5.
Zurück zum Zitat Malan E, Puglionisi A (1964) Congenital angiodysplasias of the extremities. I. Generalities and classification: venous dysplasias. J Cardiovasc Surg 5:87–130 Malan E, Puglionisi A (1964) Congenital angiodysplasias of the extremities. I. Generalities and classification: venous dysplasias. J Cardiovasc Surg 5:87–130
6.
Zurück zum Zitat Mulliken JB, Glowacki J (1982) Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg 69:412–422PubMedCrossRef Mulliken JB, Glowacki J (1982) Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg 69:412–422PubMedCrossRef
7.
Zurück zum Zitat Jackson IT, Carreno R, Potparic Z et al (1993) Hemangiomas, vascular malformations, and lymphovenous malformations: classification and methods of treatment. Plast Reconstr Surg 91:1216–1230PubMedCrossRef Jackson IT, Carreno R, Potparic Z et al (1993) Hemangiomas, vascular malformations, and lymphovenous malformations: classification and methods of treatment. Plast Reconstr Surg 91:1216–1230PubMedCrossRef
8.
Zurück zum Zitat Wassef M, Blei F, Adams D et al (2015) Vascular anomalies classification: recommendations from the International Society for the Study of Vascular Anomalies. Pediatrics 136:e203–e214PubMedCrossRef Wassef M, Blei F, Adams D et al (2015) Vascular anomalies classification: recommendations from the International Society for the Study of Vascular Anomalies. Pediatrics 136:e203–e214PubMedCrossRef
9.
Zurück zum Zitat Leon-Villapalos J, Wolfe K, Kangesu L (2005) GLUT-1: an extra diagnostic tool to differentiate between haemangiomas and vascular malformations. Br J Plast Surg 58:348–352PubMedCrossRef Leon-Villapalos J, Wolfe K, Kangesu L (2005) GLUT-1: an extra diagnostic tool to differentiate between haemangiomas and vascular malformations. Br J Plast Surg 58:348–352PubMedCrossRef
10.
Zurück zum Zitat Lopez Gutierrez JC, Tovar JA, Patron M (2005) The impact of Glut-1 marker application on the diagnosis and treatment of congenital vascular anomalies. Cir Pediatr 18:113–120PubMed Lopez Gutierrez JC, Tovar JA, Patron M (2005) The impact of Glut-1 marker application on the diagnosis and treatment of congenital vascular anomalies. Cir Pediatr 18:113–120PubMed
11.
Zurück zum Zitat Chamlin SL, Haggstrom AN, Drolet BA et al (2007) Multicenter prospective study of ulcerated hemangiomas. J Pediatr 151:684–689PubMedCrossRef Chamlin SL, Haggstrom AN, Drolet BA et al (2007) Multicenter prospective study of ulcerated hemangiomas. J Pediatr 151:684–689PubMedCrossRef
12.
Zurück zum Zitat Haggstrom AN, Drolet BA, Baselga E et al (2006) Prospective study of infantile hemangiomas: clinical characteristics predicting complications and treatment. Pediatrics 118:882–887PubMedCrossRef Haggstrom AN, Drolet BA, Baselga E et al (2006) Prospective study of infantile hemangiomas: clinical characteristics predicting complications and treatment. Pediatrics 118:882–887PubMedCrossRef
13.
Zurück zum Zitat Paltiel HJ, Burrows PE, Kozakewich HP et al (2000) Soft-tissue vascular anomalies: utility of US for diagnosis. Radiology 214:747–754PubMedCrossRef Paltiel HJ, Burrows PE, Kozakewich HP et al (2000) Soft-tissue vascular anomalies: utility of US for diagnosis. Radiology 214:747–754PubMedCrossRef
14.
Zurück zum Zitat Kassarjian A, Zurakowski D, Dubois J et al (2004) Infantile hepatic hemangiomas: clinical and imaging findings and their correlation with therapy. AJR Am J Roentgenol 182:785–795PubMedCrossRef Kassarjian A, Zurakowski D, Dubois J et al (2004) Infantile hepatic hemangiomas: clinical and imaging findings and their correlation with therapy. AJR Am J Roentgenol 182:785–795PubMedCrossRef
16.
Zurück zum Zitat Lee BB, Choe YH, Ahn JM et al (2004) The new role of magnetic resonance imaging in the contemporary diagnosis of venous malformation: can it replace angiography? J Am Coll Surg 198:549–558PubMedCrossRef Lee BB, Choe YH, Ahn JM et al (2004) The new role of magnetic resonance imaging in the contemporary diagnosis of venous malformation: can it replace angiography? J Am Coll Surg 198:549–558PubMedCrossRef
17.
Zurück zum Zitat Breugem CC, Maas M, Reekers JA et al (2001) Use of magnetic resonance imaging for the evaluation of vascular malformations of the lower extremity. Plast Reconstr Surg 108:870–877PubMedCrossRef Breugem CC, Maas M, Reekers JA et al (2001) Use of magnetic resonance imaging for the evaluation of vascular malformations of the lower extremity. Plast Reconstr Surg 108:870–877PubMedCrossRef
18.
Zurück zum Zitat Dobson MJ, Hartley RW, Ashleigh R et al (1997) MR angiography and MR imaging of symptomatic vascular malformations. Clin Radiol 52:595–602PubMedCrossRef Dobson MJ, Hartley RW, Ashleigh R et al (1997) MR angiography and MR imaging of symptomatic vascular malformations. Clin Radiol 52:595–602PubMedCrossRef
19.
Zurück zum Zitat Smith JK, Castillo M, Wilson JD (1995) MR characteristics of low-flow facial vascular malformations in children and young adults. Clin Imaging 19:109–117PubMedCrossRef Smith JK, Castillo M, Wilson JD (1995) MR characteristics of low-flow facial vascular malformations in children and young adults. Clin Imaging 19:109–117PubMedCrossRef
20.
Zurück zum Zitat Gorincour G, Kokta V, Rypens F et al (2005) Imaging characteristics of two subtypes of congenital hemangiomas: rapidly involuting congenital hemangiomas and non-involuting congenital hemangiomas. Pediatr Radiol 35:1178–1185PubMedCrossRef Gorincour G, Kokta V, Rypens F et al (2005) Imaging characteristics of two subtypes of congenital hemangiomas: rapidly involuting congenital hemangiomas and non-involuting congenital hemangiomas. Pediatr Radiol 35:1178–1185PubMedCrossRef
21.
Zurück zum Zitat Konez O, Burrows PE, Mulliken JB et al (2003) Angiographic features of rapidly involuting congenital hemangioma (RICH). Pediatr Radiol 33:15–19PubMedCrossRef Konez O, Burrows PE, Mulliken JB et al (2003) Angiographic features of rapidly involuting congenital hemangioma (RICH). Pediatr Radiol 33:15–19PubMedCrossRef
22.
Zurück zum Zitat Legiehn GM, Heran MK (2006) Classification, diagnosis, and interventional radiologic management of vascular malformations. Orthop Clin N Am 37:435–474CrossRef Legiehn GM, Heran MK (2006) Classification, diagnosis, and interventional radiologic management of vascular malformations. Orthop Clin N Am 37:435–474CrossRef
23.
Zurück zum Zitat Lowe LH, Marchant TC, Rivard DC et al (2012) Vascular malformations: classification and terminology the radiologist needs to know. Semin Roentgenol 47:106–117PubMedCrossRef Lowe LH, Marchant TC, Rivard DC et al (2012) Vascular malformations: classification and terminology the radiologist needs to know. Semin Roentgenol 47:106–117PubMedCrossRef
24.
Zurück zum Zitat Roebuck D, Sebire N, Lehmann E et al (2012) Rapidly involuting congenital haemangioma (RICH) of the liver. Pediatr Radiol 42:308–314PubMedCrossRef Roebuck D, Sebire N, Lehmann E et al (2012) Rapidly involuting congenital haemangioma (RICH) of the liver. Pediatr Radiol 42:308–314PubMedCrossRef
25.
Zurück zum Zitat Moukaddam H, Pollak J, Haims AH (2009) MRI characteristics and classification of peripheral vascular malformations and tumors. Skeletal Radiol 38:535–547PubMedCrossRef Moukaddam H, Pollak J, Haims AH (2009) MRI characteristics and classification of peripheral vascular malformations and tumors. Skeletal Radiol 38:535–547PubMedCrossRef
26.
Zurück zum Zitat Ballah D, Cahill AM, Fontalvo L et al (2011) Vascular anomalies: what they are, how to diagnose them, and how to treat them. Curr Probl Diagn Radiol 40:233–247PubMedCrossRef Ballah D, Cahill AM, Fontalvo L et al (2011) Vascular anomalies: what they are, how to diagnose them, and how to treat them. Curr Probl Diagn Radiol 40:233–247PubMedCrossRef
27.
Zurück zum Zitat Aboutalebi A, Jessup CJ, North PE et al (2012) Histopathology of vascular anomalies. Facial Plast Surg 28:545–553PubMedCrossRef Aboutalebi A, Jessup CJ, North PE et al (2012) Histopathology of vascular anomalies. Facial Plast Surg 28:545–553PubMedCrossRef
28.
Zurück zum Zitat Bivings L (1954) Spontaneous regression of angiomas in children; twenty-two years’ observation covering 236 cases. J Pediatr 45:643–647PubMedCrossRef Bivings L (1954) Spontaneous regression of angiomas in children; twenty-two years’ observation covering 236 cases. J Pediatr 45:643–647PubMedCrossRef
29.
Zurück zum Zitat Sadan N, Wolach B (1996) Treatment of hemangiomas of infants with high doses of prednisone. J Pediatr 128:141–146PubMedCrossRef Sadan N, Wolach B (1996) Treatment of hemangiomas of infants with high doses of prednisone. J Pediatr 128:141–146PubMedCrossRef
30.
Zurück zum Zitat Enjolras O, Riche MC, Merland JJ et al (1990) Management of alarming hemangiomas in infancy: a review of 25 cases. Pediatrics 85:491–498PubMed Enjolras O, Riche MC, Merland JJ et al (1990) Management of alarming hemangiomas in infancy: a review of 25 cases. Pediatrics 85:491–498PubMed
31.
Zurück zum Zitat Bennett ML, Fleischer AB Jr, Chamlin SL et al (2001) Oral corticosteroid use is effective for cutaneous hemangiomas: an evidence-based evaluation. Arch Dermatol 137:1208–1213PubMedCrossRef Bennett ML, Fleischer AB Jr, Chamlin SL et al (2001) Oral corticosteroid use is effective for cutaneous hemangiomas: an evidence-based evaluation. Arch Dermatol 137:1208–1213PubMedCrossRef
32.
Zurück zum Zitat Zarem HA, Edgerton MT (1967) Induced resolution of cavernous hemangiomas following prednisolone therapy. Plast Reconstr Surg 39:76–83PubMedCrossRef Zarem HA, Edgerton MT (1967) Induced resolution of cavernous hemangiomas following prednisolone therapy. Plast Reconstr Surg 39:76–83PubMedCrossRef
33.
Zurück zum Zitat Chim H, Gosain AK (2011) Discussion: oral prednisolone for infantile hemangioma: efficacy and safety using a standardized treatment protocol. Plast Reconstr Surg 128:753–754PubMedCrossRef Chim H, Gosain AK (2011) Discussion: oral prednisolone for infantile hemangioma: efficacy and safety using a standardized treatment protocol. Plast Reconstr Surg 128:753–754PubMedCrossRef
34.
Zurück zum Zitat Gunn T, Reece ER, Metrakos K et al (1981) Depressed T cells following neonatal steroid treatment. Pediatrics 67:61–67PubMed Gunn T, Reece ER, Metrakos K et al (1981) Depressed T cells following neonatal steroid treatment. Pediatrics 67:61–67PubMed
35.
36.
Zurück zum Zitat Egbert JE, Nelson SC (1997) Neurologic toxicity associated with interferon alfa treatment of capillary hemangioma. J AAPOS 1:190PubMedCrossRef Egbert JE, Nelson SC (1997) Neurologic toxicity associated with interferon alfa treatment of capillary hemangioma. J AAPOS 1:190PubMedCrossRef
37.
Zurück zum Zitat Barlow CF, Priebe CJ, Mulliken JB et al (1998) Spastic diplegia as a complication of interferon alfa-2a treatment of hemangiomas of infancy. J Pediatr 132:527–530PubMedCrossRef Barlow CF, Priebe CJ, Mulliken JB et al (1998) Spastic diplegia as a complication of interferon alfa-2a treatment of hemangiomas of infancy. J Pediatr 132:527–530PubMedCrossRef
38.
Zurück zum Zitat Denoyelle F, Leboulanger N, Enjolras O et al (2009) Role of propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma. Int J Pediatr Otorhinolaryngol 73:1168–1172PubMedCrossRef Denoyelle F, Leboulanger N, Enjolras O et al (2009) Role of propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma. Int J Pediatr Otorhinolaryngol 73:1168–1172PubMedCrossRef
39.
Zurück zum Zitat Bertrand J, McCuaig C, Dubois J et al (2011) Propranolol versus prednisone in the treatment of infantile hemangiomas: a retrospective comparative study. Pediatr Dermatol 28:649–654PubMedCrossRef Bertrand J, McCuaig C, Dubois J et al (2011) Propranolol versus prednisone in the treatment of infantile hemangiomas: a retrospective comparative study. Pediatr Dermatol 28:649–654PubMedCrossRef
40.
Zurück zum Zitat Price CJ, Lattouf C, Baum B et al (2011) Propranolol vs. corticosteroids for infantile hemangiomas: a multicenter retrospective analysis. Arch Dermatol 147:1371–1376PubMedCrossRef Price CJ, Lattouf C, Baum B et al (2011) Propranolol vs. corticosteroids for infantile hemangiomas: a multicenter retrospective analysis. Arch Dermatol 147:1371–1376PubMedCrossRef
41.
Zurück zum Zitat Malik MA, Menon P, Rao KL et al (2013) Effect of propranolol vs. prednisolone vs. propranolol with prednisolone in the management of infantile hemangioma: a randomized controlled study. J Pediatr Surg 48:2453–2459PubMedCrossRef Malik MA, Menon P, Rao KL et al (2013) Effect of propranolol vs. prednisolone vs. propranolol with prednisolone in the management of infantile hemangioma: a randomized controlled study. J Pediatr Surg 48:2453–2459PubMedCrossRef
42.
Zurück zum Zitat Marqueling AL, Oza V, Frieden IJ et al (2013) Propranolol and infantile hemangiomas four years later: a systematic review. Pediatr Dermatol 30:182–191PubMedCrossRef Marqueling AL, Oza V, Frieden IJ et al (2013) Propranolol and infantile hemangiomas four years later: a systematic review. Pediatr Dermatol 30:182–191PubMedCrossRef
43.
Zurück zum Zitat Lou Y, Peng WJ, Cao Y et al (2014) The effectiveness of propranolol in treating infantile haemangiomas: a meta-analysis including 35 studies. Br J Clin Pharmacol 78:44–57PubMedCrossRef Lou Y, Peng WJ, Cao Y et al (2014) The effectiveness of propranolol in treating infantile haemangiomas: a meta-analysis including 35 studies. Br J Clin Pharmacol 78:44–57PubMedCrossRef
44.
Zurück zum Zitat Drolet BA, Frommelt PC, Chamlin SL et al (2013) Initiation and use of propranolol for infantile hemangioma: report of a consensus conference. Pediatrics 131:128–140PubMedPubMedCentralCrossRef Drolet BA, Frommelt PC, Chamlin SL et al (2013) Initiation and use of propranolol for infantile hemangioma: report of a consensus conference. Pediatrics 131:128–140PubMedPubMedCentralCrossRef
45.
Zurück zum Zitat Connelly EA, Viera M, Price C et al (2009) Segmental hemangioma of infancy complicated by life-threatening arterial bleed. Pediatr Dermatol 26:469–472PubMedCrossRef Connelly EA, Viera M, Price C et al (2009) Segmental hemangioma of infancy complicated by life-threatening arterial bleed. Pediatr Dermatol 26:469–472PubMedCrossRef
46.
Zurück zum Zitat Sato Y, Frey EE, Wicklund B et al (1987) Embolization therapy in the management of infantile hemangioma with Kasabach Merritt syndrome. Pediatr Radiol 17:503–504PubMedCrossRef Sato Y, Frey EE, Wicklund B et al (1987) Embolization therapy in the management of infantile hemangioma with Kasabach Merritt syndrome. Pediatr Radiol 17:503–504PubMedCrossRef
47.
Zurück zum Zitat Fassih M, Taali L, Abada A et al (2012) Vascular tumors of the nasal cavities: a retrospective study of 10 cases. Rev Laryngol Otol Rhinol 133:87–92 Fassih M, Taali L, Abada A et al (2012) Vascular tumors of the nasal cavities: a retrospective study of 10 cases. Rev Laryngol Otol Rhinol 133:87–92
48.
Zurück zum Zitat Manunza F, Syed S, Laguda B et al (2010) Propranolol for complicated infantile haemangiomas: a case series of 30 infants. Br J Dermatol 162:466–468PubMedCrossRef Manunza F, Syed S, Laguda B et al (2010) Propranolol for complicated infantile haemangiomas: a case series of 30 infants. Br J Dermatol 162:466–468PubMedCrossRef
49.
Zurück zum Zitat Sans V, de la Roque ED, Berge J et al (2009) Propranolol for severe infantile hemangiomas: follow-up report. Pediatrics 124:e423–e431PubMedCrossRef Sans V, de la Roque ED, Berge J et al (2009) Propranolol for severe infantile hemangiomas: follow-up report. Pediatrics 124:e423–e431PubMedCrossRef
50.
Zurück zum Zitat Vercellino N, Romanini MV, Pelegrini M et al (2013) The use of propranolol for complicated infantile hemangiomas. Int J Dermatol 52:1140–1146PubMedCrossRef Vercellino N, Romanini MV, Pelegrini M et al (2013) The use of propranolol for complicated infantile hemangiomas. Int J Dermatol 52:1140–1146PubMedCrossRef
51.
Zurück zum Zitat Sadykov RR, Podmelle F, Sadykov RA et al (2013) Use of propranolol for the treatment infantile hemangiomas in the maxillofacial region. Int J Oral Maxillofac Surg 42:863–867PubMedCrossRef Sadykov RR, Podmelle F, Sadykov RA et al (2013) Use of propranolol for the treatment infantile hemangiomas in the maxillofacial region. Int J Oral Maxillofac Surg 42:863–867PubMedCrossRef
52.
Zurück zum Zitat Ben-Amitai D, Halachmi S, Zvulunov A et al (2012) Hemangiomas of the nasal tip treated with propranolol. Dermatology 225:371–375PubMedCrossRef Ben-Amitai D, Halachmi S, Zvulunov A et al (2012) Hemangiomas of the nasal tip treated with propranolol. Dermatology 225:371–375PubMedCrossRef
53.
Zurück zum Zitat Al Dosari S, Riad H (2013) Ulcerated nasal infantile haemangioma treated by oral propranolol. Dermatol Online J 19:18298PubMed Al Dosari S, Riad H (2013) Ulcerated nasal infantile haemangioma treated by oral propranolol. Dermatol Online J 19:18298PubMed
54.
Zurück zum Zitat Snir M, Reich U, Siegel R et al (2011) Refractive and structural changes in infantile periocular capillary haemangioma treated with propranolol. Eye 25:1627–1634PubMedPubMedCentralCrossRef Snir M, Reich U, Siegel R et al (2011) Refractive and structural changes in infantile periocular capillary haemangioma treated with propranolol. Eye 25:1627–1634PubMedPubMedCentralCrossRef
55.
Zurück zum Zitat Saint-Jean M, Leaute-Labreze C, Mazereeuw-Hautier J et al (2011) Propranolol for treatment of ulcerated infantile hemangiomas. J Am Acad Dermatol 64:827–832PubMedCrossRef Saint-Jean M, Leaute-Labreze C, Mazereeuw-Hautier J et al (2011) Propranolol for treatment of ulcerated infantile hemangiomas. J Am Acad Dermatol 64:827–832PubMedCrossRef
56.
Zurück zum Zitat Hermans DJ, van Beynum IM, Schultze Kool LJ et al (2011) Propranolol, a very promising treatment for ulceration in infantile hemangiomas: a study of 20 cases with matched historical controls. J Am Acad Dermatol 64:833–838PubMedCrossRef Hermans DJ, van Beynum IM, Schultze Kool LJ et al (2011) Propranolol, a very promising treatment for ulceration in infantile hemangiomas: a study of 20 cases with matched historical controls. J Am Acad Dermatol 64:833–838PubMedCrossRef
57.
Zurück zum Zitat Goswamy J, Aggarwal R, Bruce IA et al (2013) Kasabach-Merritt syndrome in a child with upper airway compromise and spontaneous periorbital bruising. Ear Nose Throat J 92, E16PubMed Goswamy J, Aggarwal R, Bruce IA et al (2013) Kasabach-Merritt syndrome in a child with upper airway compromise and spontaneous periorbital bruising. Ear Nose Throat J 92, E16PubMed
58.
Zurück zum Zitat Yoon K, Lee YJ, Park DW et al (2013) Transarterial embolization of a cervicofacial hemangioma associated with Kasabach-Merritt syndrome in a premature neonate. J Vasc Interv Radiol 24:1934–1936PubMedCrossRef Yoon K, Lee YJ, Park DW et al (2013) Transarterial embolization of a cervicofacial hemangioma associated with Kasabach-Merritt syndrome in a premature neonate. J Vasc Interv Radiol 24:1934–1936PubMedCrossRef
59.
Zurück zum Zitat Buckmiller L, Dyamenahalli U, Richter GT (2009) Propranolol for airway hemangiomas: case report of novel treatment. Laryngoscope 119:2051–2054PubMedCrossRef Buckmiller L, Dyamenahalli U, Richter GT (2009) Propranolol for airway hemangiomas: case report of novel treatment. Laryngoscope 119:2051–2054PubMedCrossRef
60.
Zurück zum Zitat Fellows KE, Hoffer FA, Markowitz RI et al (1991) Multiple collaterals to hepatic infantile hemangioendotheliomas and arteriovenous malformations: effect on embolization. Radiology 181:813–818PubMedCrossRef Fellows KE, Hoffer FA, Markowitz RI et al (1991) Multiple collaterals to hepatic infantile hemangioendotheliomas and arteriovenous malformations: effect on embolization. Radiology 181:813–818PubMedCrossRef
61.
Zurück zum Zitat Truong MT, Perkins JA, Messner AH et al (2010) Propranolol for the treatment of airway hemangiomas: a case series and treatment algorithm. Int J Pediatr Otorhinolaryngol 74:1043–1048PubMedCrossRef Truong MT, Perkins JA, Messner AH et al (2010) Propranolol for the treatment of airway hemangiomas: a case series and treatment algorithm. Int J Pediatr Otorhinolaryngol 74:1043–1048PubMedCrossRef
62.
Zurück zum Zitat Christison-Lagay ER, Burrows PE, Alomari A et al (2007) Hepatic hemangiomas: subtype classification and development of a clinical practice algorithm and registry. J Pediatr Surg 42:62–67PubMedCrossRef Christison-Lagay ER, Burrows PE, Alomari A et al (2007) Hepatic hemangiomas: subtype classification and development of a clinical practice algorithm and registry. J Pediatr Surg 42:62–67PubMedCrossRef
63.
Zurück zum Zitat Beltramello A, Benati A, Perini S et al (1989) Interventional angiography in neuropediatrics. Childs Nerv Syst 5:87–93PubMedCrossRef Beltramello A, Benati A, Perini S et al (1989) Interventional angiography in neuropediatrics. Childs Nerv Syst 5:87–93PubMedCrossRef
64.
Zurück zum Zitat Vildy S, Macher J, Abasq-Thomas C et al (2015) Life-threatening hemorrhaging in neonatal ulcerated congenital hemangioma: two case reports. JAMA Dermatol 151:422–425PubMedCrossRef Vildy S, Macher J, Abasq-Thomas C et al (2015) Life-threatening hemorrhaging in neonatal ulcerated congenital hemangioma: two case reports. JAMA Dermatol 151:422–425PubMedCrossRef
65.
Zurück zum Zitat Enomoto Y, Yoshimura S, Egashira Y et al (2011) Transarterial embolization for cervical hemangioma associated with Kasabach-Merritt syndrome. Neurol Med Chir 51:375–378CrossRef Enomoto Y, Yoshimura S, Egashira Y et al (2011) Transarterial embolization for cervical hemangioma associated with Kasabach-Merritt syndrome. Neurol Med Chir 51:375–378CrossRef
66.
Zurück zum Zitat Liu XJ, Qin ZP, Tai MZ (2009) Angiographic classification and sclerotic therapy of maxillofacial cavernous haemangiomas: a report of 204 cases. J Int Med Res 37:1285–1292PubMedCrossRef Liu XJ, Qin ZP, Tai MZ (2009) Angiographic classification and sclerotic therapy of maxillofacial cavernous haemangiomas: a report of 204 cases. J Int Med Res 37:1285–1292PubMedCrossRef
67.
Zurück zum Zitat Stanley P, Grinnell VS, Stanton RE et al (1983) Therapeutic embolization of infantile hepatic hemangioma with polyvinyl alcohol. AJR Am J Roentgenol 141:1047–1051PubMedCrossRef Stanley P, Grinnell VS, Stanton RE et al (1983) Therapeutic embolization of infantile hepatic hemangioma with polyvinyl alcohol. AJR Am J Roentgenol 141:1047–1051PubMedCrossRef
68.
Zurück zum Zitat Stier MF, Glick SA, Hirsch RJ (2008) Laser treatment of pediatric vascular lesions: port wine stains and hemangiomas. J Am Acad Dermatol 58:261–285PubMedCrossRef Stier MF, Glick SA, Hirsch RJ (2008) Laser treatment of pediatric vascular lesions: port wine stains and hemangiomas. J Am Acad Dermatol 58:261–285PubMedCrossRef
69.
Zurück zum Zitat Landthaler M, Hohenleutner U, El-Raheem TA (1995) Laser therapy of childhood haemangiomas. Br J Dermatol 133:275–281PubMedCrossRef Landthaler M, Hohenleutner U, El-Raheem TA (1995) Laser therapy of childhood haemangiomas. Br J Dermatol 133:275–281PubMedCrossRef
70.
Zurück zum Zitat Raulin C, Greve B (2001) Retrospective clinical comparison of hemangioma treatment by flashlamp-pumped (585 nm) and frequency-doubled Nd:YAG (532 nm) lasers. Lasers Surg Med 28:40–43PubMedCrossRef Raulin C, Greve B (2001) Retrospective clinical comparison of hemangioma treatment by flashlamp-pumped (585 nm) and frequency-doubled Nd:YAG (532 nm) lasers. Lasers Surg Med 28:40–43PubMedCrossRef
71.
Zurück zum Zitat David LR, Malek MM, Argenta LC (2003) Efficacy of pulse dye laser therapy for the treatment of ulcerated haemangiomas: a review of 78 patients. Br J Plast Surg 56:317–327PubMedCrossRef David LR, Malek MM, Argenta LC (2003) Efficacy of pulse dye laser therapy for the treatment of ulcerated haemangiomas: a review of 78 patients. Br J Plast Surg 56:317–327PubMedCrossRef
72.
Zurück zum Zitat Hohenleutner S, Badur-Ganter E, Landthaler M et al (2001) Long-term results in the treatment of childhood hemangioma with the flashlamp-pumped pulsed dye laser: an evaluation of 617 cases. Lasers Surg Med 28:273–277PubMedCrossRef Hohenleutner S, Badur-Ganter E, Landthaler M et al (2001) Long-term results in the treatment of childhood hemangioma with the flashlamp-pumped pulsed dye laser: an evaluation of 617 cases. Lasers Surg Med 28:273–277PubMedCrossRef
73.
Zurück zum Zitat Witman PM, Wagner AM, Scherer K et al (2006) Complications following pulsed dye laser treatment of superficial hemangiomas. Lasers Surg Med 38:116–123PubMedCrossRef Witman PM, Wagner AM, Scherer K et al (2006) Complications following pulsed dye laser treatment of superficial hemangiomas. Lasers Surg Med 38:116–123PubMedCrossRef
74.
Zurück zum Zitat Michel JL (2003) Treatment of hemangiomas with 595 nm pulsed dye laser dermobeam. Eur J Dermatol 13:136–141PubMed Michel JL (2003) Treatment of hemangiomas with 595 nm pulsed dye laser dermobeam. Eur J Dermatol 13:136–141PubMed
75.
Zurück zum Zitat Burstein FD, Williams JK, Schwentker AR et al (2006) Intralesional laser therapy treatment for hemangiomas: technical evolution. J Craniofac Surg 17:756–760PubMedCrossRef Burstein FD, Williams JK, Schwentker AR et al (2006) Intralesional laser therapy treatment for hemangiomas: technical evolution. J Craniofac Surg 17:756–760PubMedCrossRef
76.
Zurück zum Zitat McCuaig CC, Cohen L, Powell J et al (2013) Therapy of ulcerated hemangiomas. J Cutan Med Surg 17:233–242PubMedCrossRef McCuaig CC, Cohen L, Powell J et al (2013) Therapy of ulcerated hemangiomas. J Cutan Med Surg 17:233–242PubMedCrossRef
77.
Zurück zum Zitat Macarthur CJ (2006) Head and neck hemangiomas of infancy. Curr Opin Otolaryngol Head Neck Surg 14:397–405PubMedCrossRef Macarthur CJ (2006) Head and neck hemangiomas of infancy. Curr Opin Otolaryngol Head Neck Surg 14:397–405PubMedCrossRef
78.
Zurück zum Zitat Mendiratta V, Varghese B, Chander R et al (2013) Successful management of airway hemangioma with propranolol. Int J Dermatol 52:750–752PubMedCrossRef Mendiratta V, Varghese B, Chander R et al (2013) Successful management of airway hemangioma with propranolol. Int J Dermatol 52:750–752PubMedCrossRef
79.
Zurück zum Zitat Anderson de Moreno LC, Matt BH, Montgomery G et al (2013) Propranolol in the treatment of upper airway hemangiomas. Ear Nose Throat J 92:209–214PubMed Anderson de Moreno LC, Matt BH, Montgomery G et al (2013) Propranolol in the treatment of upper airway hemangiomas. Ear Nose Throat J 92:209–214PubMed
80.
Zurück zum Zitat Broeks IJ, Hermans DJ, Dassel AC et al (2013) Propranolol treatment in life-threatening airway hemangiomas: a case series and review of literature. Int J Pediatr Otorhinolaryngol 77:1791–1800PubMedCrossRef Broeks IJ, Hermans DJ, Dassel AC et al (2013) Propranolol treatment in life-threatening airway hemangiomas: a case series and review of literature. Int J Pediatr Otorhinolaryngol 77:1791–1800PubMedCrossRef
81.
Zurück zum Zitat Rosbe KW, Suh KY, Meyer AK et al (2010) Propranolol in the management of airway infantile hemangiomas. Arch Otolaryngol Head Neck Surg 136:658–665PubMedCrossRef Rosbe KW, Suh KY, Meyer AK et al (2010) Propranolol in the management of airway infantile hemangiomas. Arch Otolaryngol Head Neck Surg 136:658–665PubMedCrossRef
82.
Zurück zum Zitat Metry D, Frieden IJ, Hess C et al (2013) Propranolol use in PHACE syndrome with cervical and intracranial arterial anomalies: collective experience in 32 infants. Pediatr Dermatol 30:71–89PubMedCrossRef Metry D, Frieden IJ, Hess C et al (2013) Propranolol use in PHACE syndrome with cervical and intracranial arterial anomalies: collective experience in 32 infants. Pediatr Dermatol 30:71–89PubMedCrossRef
83.
Zurück zum Zitat Metry DW, Haggstrom AN, Drolet BA et al (2006) A prospective study of PHACE syndrome in infantile hemangiomas: demographic features, clinical findings, and complications. Am J Med Genet A 140:975–986PubMedCrossRef Metry DW, Haggstrom AN, Drolet BA et al (2006) A prospective study of PHACE syndrome in infantile hemangiomas: demographic features, clinical findings, and complications. Am J Med Genet A 140:975–986PubMedCrossRef
84.
Zurück zum Zitat Vlastarakos PV, Papacharalampous GX, Chrysostomou M et al (2012) Propranolol is an effective treatment for airway haemangiomas: a critical analysis and meta-analysis of published interventional studies. Acta Otorhinolaryngol Ital 32:213–221PubMedPubMedCentral Vlastarakos PV, Papacharalampous GX, Chrysostomou M et al (2012) Propranolol is an effective treatment for airway haemangiomas: a critical analysis and meta-analysis of published interventional studies. Acta Otorhinolaryngol Ital 32:213–221PubMedPubMedCentral
85.
Zurück zum Zitat Hernandez-Martin S, Lopez-Gutierrez JC, Lopez-Fernandez S et al (2012) Brain perfusion SPECT in patients with PHACES syndrome under propranolol treatment. Eur J Pediatr Surg 22:54–59PubMedCrossRef Hernandez-Martin S, Lopez-Gutierrez JC, Lopez-Fernandez S et al (2012) Brain perfusion SPECT in patients with PHACES syndrome under propranolol treatment. Eur J Pediatr Surg 22:54–59PubMedCrossRef
86.
Zurück zum Zitat Peridis S, Pilgrim G, Athanasopoulos I et al (2011) A meta-analysis on the effectiveness of propranolol for the treatment of infantile airway haemangiomas. Int J Pediatr Otorhinolaryngol 75:455–460PubMedCrossRef Peridis S, Pilgrim G, Athanasopoulos I et al (2011) A meta-analysis on the effectiveness of propranolol for the treatment of infantile airway haemangiomas. Int J Pediatr Otorhinolaryngol 75:455–460PubMedCrossRef
87.
Zurück zum Zitat Komiyama M, Nakajima H, Kitano S et al (2000) Endovascular treatment of huge cervicofacial hemangioma complicated by Kasabach-Merritt syndrome. Pediatr Neurosurg 33:26–30PubMedCrossRef Komiyama M, Nakajima H, Kitano S et al (2000) Endovascular treatment of huge cervicofacial hemangioma complicated by Kasabach-Merritt syndrome. Pediatr Neurosurg 33:26–30PubMedCrossRef
88.
Zurück zum Zitat Zhou JX, Huang JW, Wu H et al (2013) Successful liver resection in a giant hemangioma with intestinal obstruction after embolization. World J Gastroenterol 19:2974–2978PubMedPubMedCentral Zhou JX, Huang JW, Wu H et al (2013) Successful liver resection in a giant hemangioma with intestinal obstruction after embolization. World J Gastroenterol 19:2974–2978PubMedPubMedCentral
89.
Zurück zum Zitat Dickie B, Dasgupta R, Nair R et al (2009) Spectrum of hepatic hemangiomas: management and outcome. J Pediatr Surg 44:125–133PubMedCrossRef Dickie B, Dasgupta R, Nair R et al (2009) Spectrum of hepatic hemangiomas: management and outcome. J Pediatr Surg 44:125–133PubMedCrossRef
90.
Zurück zum Zitat Mo JQ, Dimashkieh HH, Bove KE (2004) GLUT1 endothelial reactivity distinguishes hepatic infantile hemangioma from congenital hepatic vascular malformation with associated capillary proliferation. Hum Pathol 35:200–209PubMedCrossRef Mo JQ, Dimashkieh HH, Bove KE (2004) GLUT1 endothelial reactivity distinguishes hepatic infantile hemangioma from congenital hepatic vascular malformation with associated capillary proliferation. Hum Pathol 35:200–209PubMedCrossRef
91.
Zurück zum Zitat Hogeling M, Adams S, Wargon O (2011) A randomized controlled trial of propranolol for infantile hemangiomas. Pediatrics 128:e259–e266PubMedCrossRef Hogeling M, Adams S, Wargon O (2011) A randomized controlled trial of propranolol for infantile hemangiomas. Pediatrics 128:e259–e266PubMedCrossRef
92.
Zurück zum Zitat Bagazgoitia L, Torrelo A, Gutierrez JC et al (2011) Propranolol for infantile hemangiomas. Pediatr Dermatol 28:108–114PubMedCrossRef Bagazgoitia L, Torrelo A, Gutierrez JC et al (2011) Propranolol for infantile hemangiomas. Pediatr Dermatol 28:108–114PubMedCrossRef
93.
Zurück zum Zitat Schupp CJ, Kleber JB, Gunther P et al (2011) Propranolol therapy in 55 infants with infantile hemangioma: dosage, duration, adverse effects, and outcome. Pediatr Dermatol 28:640–644PubMedCrossRef Schupp CJ, Kleber JB, Gunther P et al (2011) Propranolol therapy in 55 infants with infantile hemangioma: dosage, duration, adverse effects, and outcome. Pediatr Dermatol 28:640–644PubMedCrossRef
94.
Zurück zum Zitat Bertrand J, Sammour R, McCuaig C et al (2012) Propranolol in the treatment of problematic infantile hemangioma: review of 35 consecutive patients from a vascular anomalies clinic. J Cutan Med Surg 16:317–323PubMed Bertrand J, Sammour R, McCuaig C et al (2012) Propranolol in the treatment of problematic infantile hemangioma: review of 35 consecutive patients from a vascular anomalies clinic. J Cutan Med Surg 16:317–323PubMed
95.
Zurück zum Zitat Holmes WJ, Mishra A, Gorst C et al (2011) Propranolol as first-line treatment for rapidly proliferating infantile haemangiomas. J Plast Reconstr Aesthet Surg 64:445–451PubMedCrossRef Holmes WJ, Mishra A, Gorst C et al (2011) Propranolol as first-line treatment for rapidly proliferating infantile haemangiomas. J Plast Reconstr Aesthet Surg 64:445–451PubMedCrossRef
96.
Zurück zum Zitat Buckmiller LM, Munson PD, Dyamenahalli U et al (2010) Propranolol for infantile hemangiomas: early experience at a tertiary vascular anomalies center. Laryngoscope 120:676–681PubMedCrossRef Buckmiller LM, Munson PD, Dyamenahalli U et al (2010) Propranolol for infantile hemangiomas: early experience at a tertiary vascular anomalies center. Laryngoscope 120:676–681PubMedCrossRef
97.
Zurück zum Zitat Shah S, Frieden IJ (2013) Treatment of infantile hemangiomas with beta-blockers: a review. Skin Therapy Lett 18:5–7PubMed Shah S, Frieden IJ (2013) Treatment of infantile hemangiomas with beta-blockers: a review. Skin Therapy Lett 18:5–7PubMed
98.
Zurück zum Zitat Eivazi B, Cremer HJ, Mangold C et al (2011) Hemangiomas of the nasal tip: an approach to a therapeutic challenge. Int J Pediatr Otorhinolaryngol 75:368–375PubMedCrossRef Eivazi B, Cremer HJ, Mangold C et al (2011) Hemangiomas of the nasal tip: an approach to a therapeutic challenge. Int J Pediatr Otorhinolaryngol 75:368–375PubMedCrossRef
99.
Zurück zum Zitat Léauté-Labrèze C, Hoeger P, Mazereeuw-Hautier J et al (2015) A randomized, controlled trial of oral propranolol in infantile hemangioma. N Engl J Med 372:735–746PubMedCrossRef Léauté-Labrèze C, Hoeger P, Mazereeuw-Hautier J et al (2015) A randomized, controlled trial of oral propranolol in infantile hemangioma. N Engl J Med 372:735–746PubMedCrossRef
100.
Zurück zum Zitat Perkins JA, Chen BS, Saltzman B et al (2014) Propranolol therapy for reducing the number of nasal infantile hemangioma invasive procedures. JAMA Otolaryngol Head Neck Surg 140:220–227PubMedCrossRef Perkins JA, Chen BS, Saltzman B et al (2014) Propranolol therapy for reducing the number of nasal infantile hemangioma invasive procedures. JAMA Otolaryngol Head Neck Surg 140:220–227PubMedCrossRef
101.
Zurück zum Zitat Kim LH, Hogeling M, Wargon O et al (2011) Propranolol: useful therapeutic agent for the treatment of ulcerated infantile hemangiomas. J Pediatr Surg 46:759–763PubMedCrossRef Kim LH, Hogeling M, Wargon O et al (2011) Propranolol: useful therapeutic agent for the treatment of ulcerated infantile hemangiomas. J Pediatr Surg 46:759–763PubMedCrossRef
102.
Zurück zum Zitat Yeh I, Bruckner AL, Sanchez R et al (2011) Diffuse infantile hepatic hemangiomas: a report of four cases successfully managed with medical therapy. Pediatr Dermatol 28:267–275PubMedCrossRef Yeh I, Bruckner AL, Sanchez R et al (2011) Diffuse infantile hepatic hemangiomas: a report of four cases successfully managed with medical therapy. Pediatr Dermatol 28:267–275PubMedCrossRef
103.
Zurück zum Zitat Mazereeuw-Hautier J, Hoeger PH, Benlahrech S et al (2010) Efficacy of propranolol in hepatic infantile hemangiomas with diffuse neonatal hemangiomatosis. J Pediatr 157:340–342PubMedCrossRef Mazereeuw-Hautier J, Hoeger PH, Benlahrech S et al (2010) Efficacy of propranolol in hepatic infantile hemangiomas with diffuse neonatal hemangiomatosis. J Pediatr 157:340–342PubMedCrossRef
104.
Zurück zum Zitat Brauer JA, Geronemus RG (2013) Laser treatment in the management of infantile hemangiomas and capillary vascular malformations. Tech Vasc Interv Radiol 16:51–54PubMedCrossRef Brauer JA, Geronemus RG (2013) Laser treatment in the management of infantile hemangiomas and capillary vascular malformations. Tech Vasc Interv Radiol 16:51–54PubMedCrossRef
105.
Zurück zum Zitat McHugh K, Burrows PE (1992) Infantile hepatic hemangioendotheliomas: significance of portal venous and systemic collateral arterial supply. J Vasc Interv Radiol 3:337–344PubMedCrossRef McHugh K, Burrows PE (1992) Infantile hepatic hemangioendotheliomas: significance of portal venous and systemic collateral arterial supply. J Vasc Interv Radiol 3:337–344PubMedCrossRef
106.
Zurück zum Zitat Seo HI, Jo HJ, Sim MS et al (2009) Right trisegmentectomy with thoracoabdominal approach after transarterial embolization for giant hepatic hemangioma. World J Gastroenterol 15:3437–3439PubMedPubMedCentralCrossRef Seo HI, Jo HJ, Sim MS et al (2009) Right trisegmentectomy with thoracoabdominal approach after transarterial embolization for giant hepatic hemangioma. World J Gastroenterol 15:3437–3439PubMedPubMedCentralCrossRef
107.
Zurück zum Zitat Jangjoo A, Mehrabi Bahar M, Aliakbarian M (2010) Ruptured giant hepatic hemangioma: report of a case. Acta Med Iran 48:419–422PubMed Jangjoo A, Mehrabi Bahar M, Aliakbarian M (2010) Ruptured giant hepatic hemangioma: report of a case. Acta Med Iran 48:419–422PubMed
108.
Zurück zum Zitat Kayan M, Cetin M, Aktas AR et al (2012) Pre-operative arterial embolization of symptomatic giant hemangioma of the liver. Prague Med Rep 113:166–171PubMedCrossRef Kayan M, Cetin M, Aktas AR et al (2012) Pre-operative arterial embolization of symptomatic giant hemangioma of the liver. Prague Med Rep 113:166–171PubMedCrossRef
109.
Zurück zum Zitat Lupinacci RM, Szejnfeld D, Farah JF (2011) Spontaneous rupture of a giant hepatic hemangioma. Sequential treatment with preoperative transcatheter arterial embolization and conservative hepatectomy. G Chir 32:469–472PubMed Lupinacci RM, Szejnfeld D, Farah JF (2011) Spontaneous rupture of a giant hepatic hemangioma. Sequential treatment with preoperative transcatheter arterial embolization and conservative hepatectomy. G Chir 32:469–472PubMed
110.
Zurück zum Zitat Akamatsu N, Sugawara Y, Komagome M et al (2010) Giant liver hemangioma resected by trisectorectomy after efficient volume reduction by transcatheter arterial embolization: a case report. J Med Case Rep 4:283PubMedPubMedCentralCrossRef Akamatsu N, Sugawara Y, Komagome M et al (2010) Giant liver hemangioma resected by trisectorectomy after efficient volume reduction by transcatheter arterial embolization: a case report. J Med Case Rep 4:283PubMedPubMedCentralCrossRef
111.
Zurück zum Zitat Jain V, Ramachandran V, Garg R et al (2010) Spontaneous rupture of a giant hepatic hemangioma — sequential management with transcatheter arterial embolization and resection. Saudi J Gastroenterol 16:116–119PubMedPubMedCentralCrossRef Jain V, Ramachandran V, Garg R et al (2010) Spontaneous rupture of a giant hepatic hemangioma — sequential management with transcatheter arterial embolization and resection. Saudi J Gastroenterol 16:116–119PubMedPubMedCentralCrossRef
112.
Zurück zum Zitat Casasco A, Herbreteau D, Houdart E et al (1994) Devascularization of craniofacial tumors by percutaneous tumor puncture. AJNR Am J Neuroradiol 15:1233–1239PubMed Casasco A, Herbreteau D, Houdart E et al (1994) Devascularization of craniofacial tumors by percutaneous tumor puncture. AJNR Am J Neuroradiol 15:1233–1239PubMed
113.
Zurück zum Zitat Luo Q, Zhao F (2011) How to use bleomycin A5 for infantile maxillofacial haemangiomas: clinical evaluation of 82 consecutive cases. J Craniomaxillofac Surg 39:482–486PubMedCrossRef Luo Q, Zhao F (2011) How to use bleomycin A5 for infantile maxillofacial haemangiomas: clinical evaluation of 82 consecutive cases. J Craniomaxillofac Surg 39:482–486PubMedCrossRef
114.
Zurück zum Zitat Jayakumar PN, Desai SV, Kovoor JM et al (2002) Percutaneous embolization of mandibular hemangioma: a case report. J Oral Maxillofac Surg 60:945–948PubMedCrossRef Jayakumar PN, Desai SV, Kovoor JM et al (2002) Percutaneous embolization of mandibular hemangioma: a case report. J Oral Maxillofac Surg 60:945–948PubMedCrossRef
115.
Zurück zum Zitat Hou J, Wang M, Tang H et al (2011) Pingyangmycin sclerotherapy for infantile hemangiomas in oral and maxillofacial regions: an evaluation of 66 consecutive patients. Int J Oral Maxillofac Surg 40:1246–1251PubMedCrossRef Hou J, Wang M, Tang H et al (2011) Pingyangmycin sclerotherapy for infantile hemangiomas in oral and maxillofacial regions: an evaluation of 66 consecutive patients. Int J Oral Maxillofac Surg 40:1246–1251PubMedCrossRef
116.
117.
118.
Zurück zum Zitat Reddy KK, Blei F, Brauer JA et al (2013) Retrospective study of the treatment of infantile hemangiomas using a combination of propranolol and pulsed dye laser. Dermatol Surg 39:923–933PubMedCrossRef Reddy KK, Blei F, Brauer JA et al (2013) Retrospective study of the treatment of infantile hemangiomas using a combination of propranolol and pulsed dye laser. Dermatol Surg 39:923–933PubMedCrossRef
119.
Zurück zum Zitat Esterly NB (1996) Cutaneous hemangiomas, vascular stains and malformations, and associated syndromes. Curr Probl Pediatr 26:3–39PubMed Esterly NB (1996) Cutaneous hemangiomas, vascular stains and malformations, and associated syndromes. Curr Probl Pediatr 26:3–39PubMed
120.
Zurück zum Zitat Daramola OO, Chun RH, Nash JJ et al (2011) Surgical treatment of infantile hemangioma in a multidisciplinary vascular anomalies clinic. Int J Pediatr Otorhinolaryngol 75:1271–1274PubMedCrossRef Daramola OO, Chun RH, Nash JJ et al (2011) Surgical treatment of infantile hemangioma in a multidisciplinary vascular anomalies clinic. Int J Pediatr Otorhinolaryngol 75:1271–1274PubMedCrossRef
Metadaten
Titel
The changing face of complicated infantile hemangioma treatment
verfasst von
Deanna Menapace
Mario Mitkov
Richard Towbin
Marcia Hogeling
Publikationsdatum
23.07.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Radiology / Ausgabe 11/2016
Print ISSN: 0301-0449
Elektronische ISSN: 1432-1998
DOI
https://doi.org/10.1007/s00247-016-3643-6

Weitere Artikel der Ausgabe 11/2016

Pediatric Radiology 11/2016 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.